Non-healthcare costs of hepatitis C: a systematic review-Reference-Cited by-同舟云学术

Non-healthcare costs of hepatitis C: a systematic review

Published:2017-09-08 Issue:1 Volume:12 Page:19-30
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Pascual-Argente Natàlia¹²^ORCID,Puig-Junoy Jaume¹²^ORCID,Llagostera-Punzano Anna²

Affiliation:

1. UPF Barcelona School of Management, Pompeu Fabra University, Barcelona, Spain

2. Department of Economics and Business. Center for Research in Health and Economics (CRES-UPF), Pompeu Fabra University, Barcelona, Spain

Funder

IMS Health

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2017.1373016

Reference67 articles.

1. World Health Organization.Global hepatitis report, 2017 [Internet]. Geneva: World Health Organization. 2017; [Cited 2017 May 16]. Available from: http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1.

2. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

3. Natural History and Management of Hepatitis C: Does Sex Play a Role?

4. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

5. Hepatitis C

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of hepatitis C—associated premature deaths on labour productivity losses in Spain: a ten-year analysis;The European Journal of Health Economics;2022-11-10

2. Perceived Stress in Hepatitis C Virus Infected Patients under the DAA-Based Therapy;Diagnostics;2022-05-09

3. Economic burden of chronic viral hepatitis C;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2022-01-15

4. Value appropriation in hepatitis C;The European Journal of Health Economics;2021-12-02

5. Implementation and evaluation of an educational intervention for safer injection in people who inject drugs in Europe: a multi-country mixed-methods study;International Journal of Drug Policy;2021-01